{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T02:52:43Z","timestamp":1777344763325,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,21]]},"DOI":"10.7759\/cureus.74163","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T16:55:31Z","timestamp":1732208131000},"source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of Iron Deficiency Anemia in Gynecological Cancer Patients Undergoing Treatment: A Two-Institution Retrospective Study"],"prefix":"10.7759","author":[{"given":"Taro","family":"Yagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuto","family":"Kinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Iwamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Futa","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenjiro","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichirou","family":"Morishige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.102837","article-title":"Recent update in the pathogenesis and treatment of chemotherapy and cancer induced anemia","volume":"145","author":"Abdel-Razeq H","year":"2020","unstructured":"Abdel-Razeq H, Hashem H. Recent update in the pathogenesis and treatment of chemotherapy and cancer induced anemia. Crit Rev Oncol Hematol. 2020, 145:102837. 10.1016\/j.critrevonc.2019.102837","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.3531","article-title":"Red blood cell transfusion practices for patients with cervical cancer undergoing radiotherapy","volume":"4","author":"Zayed S","year":"2021","unstructured":"Zayed S, Nguyen TK, Lin C, et al.. Red blood cell transfusion practices for patients with cervical cancer undergoing radiotherapy. JAMA Netw Open. 2021, 4:e213531. 10.1001\/jamanetworkopen.2021.3531","journal-title":"JAMA Netw Open"},{"key":"ref3","unstructured":"National Comprehensive Cancer Network. NCCN guidelines, Hematopoietic growth factors, version 3. (2024). https.\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/growthfactors.pdf."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx758","article-title":"Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines","volume":"29","author":"Aapro M","year":"2018","unstructured":"Aapro M, Beguin Y, Bokemeyer C, et al.. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2018, 29:iv96-iv110. 10.1093\/annonc\/mdx758","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7638","article-title":"Prevalence of anemia and compliance with NCCN guidelines for evaluation and treatment of anemia in patients with gynecologic cancer","volume":"19","author":"Hufnagel DH","year":"2021","unstructured":"Hufnagel DH, Mehta ST, Ezekwe C, Brown AJ, Beeghly-Fadiel A, Prescott LS. Prevalence of anemia and compliance with NCCN guidelines for evaluation and treatment of anemia in patients with gynecologic cancer. J Natl Compr Canc Netw. 2021, 19:513-20. 10.6004\/jnccn.2020.7638","journal-title":"J Natl Compr Canc Netw"},{"key":"ref6","article-title":"Serum ferritin levels and transferrin saturation in men with prostate cancer","volume":"96","author":"Kuvibidila SR","year":"2004","unstructured":"Kuvibidila SR, Gauthier T, Rayford W. Serum ferritin levels and transferrin saturation in men with prostate cancer. J Natl Med Assoc. 2004, 96:641-9.","journal-title":"J Natl Med Assoc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2005.00789.x","article-title":"The prevalence of iron deficiency among patients presenting with colorectal cancer","volume":"7","author":"Beale AL","year":"2005","unstructured":"Beale AL, Penney MD, Allison MC. The prevalence of iron deficiency among patients presenting with colorectal cancer. Colorectal Dis. 2005, 7:398-402. 10.1111\/j.1463-1318.2005.00789.x","journal-title":"Colorectal Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt118","article-title":"Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia","volume":"24","author":"Ludwig H","year":"2013","unstructured":"Ludwig H, M\u00fcld\u00fcr E, Endler G, H\u00fcbl W. Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia. Ann Oncol. 2013, 24:1886-92. 10.1093\/annonc\/mdt118","journal-title":"Ann Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-014-0677-3","article-title":"Questionnaire-based survey on chemotherapy-induced anemia","volume":"19","author":"Tanaka A","year":"2014","unstructured":"Tanaka A, Yoshino I, Makino S, et al.. Questionnaire-based survey on chemotherapy-induced anemia. Int J Clin Oncol. 2014, 19:411-20. 10.1007\/s10147-014-0677-3","journal-title":"Int J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_390876","article-title":"Managing adverse effects associated with poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a synthesis of clinical trial and real-world data","volume":"43","author":"Friedlander M","year":"2023","unstructured":"Friedlander M, Lee YC, Tew WP. Managing adverse effects associated with poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a synthesis of clinical trial and real-world data. Am Soc Clin Oncol Educ Book. 2023, 43:e390876. 10.1200\/EDBK_390876","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2014.10.006","article-title":"A review of relative dose intensity and survival in patients with metastatic solid tumors","volume":"93","author":"Havrilesky LJ","year":"2015","unstructured":"Havrilesky LJ, Reiner M, Morrow PK, Watson H, Crawford J. A review of relative dose intensity and survival in patients with metastatic solid tumors. Crit Rev Oncol Hematol. 2015, 93:203-10. 10.1016\/j.critrevonc.2014.10.006","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000496967","article-title":"The role of intravenous iron in the treatment of anemia associated with cancer and chemotherapy","volume":"142","author":"Rodgers GM","year":"2019","unstructured":"Rodgers GM, Gilreath JA. The role of intravenous iron in the treatment of anemia associated with cancer and chemotherapy. Acta Haematol. 2019, 142:13-20. 10.1159\/000496967","journal-title":"Acta Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.12.004","article-title":"Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy","volume":"116","author":"Dangsuwan P","year":"2010","unstructured":"Dangsuwan P, Manchana T. Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. Gynecol Oncol. 2010, 116:522-5. 10.1016\/j.ygyno.2009.12.004","journal-title":"Gynecol Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.09.028","article-title":"Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy","volume":"131","author":"Athibovonsuk P","year":"2013","unstructured":"Athibovonsuk P, Manchana T, Sirisabya N. Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy. Gynecol Oncol. 2013, 131:679-82. 10.1016\/j.ygyno.2013.09.028","journal-title":"Gynecol Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/314738-prevalence-of-iron-deficiency-anemia-in-gynecological-cancer-patients-undergoing-treatment-a-two-institution-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T16:55:33Z","timestamp":1732208133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/314738-prevalence-of-iron-deficiency-anemia-in-gynecological-cancer-patients-undergoing-treatment-a-two-institution-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.74163","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,21]]}}}